In recent years, GLP-1 medications have become a focal point in the medical community due to their innovative treatment mechanisms, significant therapeutic efficacy, and broad development prospects
Effects of GLP-1RAs in clinical trials Clinical studies with focus on atherosclerotic CV disease
We believe that testing is not a shortcut to a diagnosis, but a tool to help you see the bigger picture
The result, in preclinical and early clinical data, is maintained blood sugar regulation with reduced nausea and vomiting
That variation is driving a lot of interest in understanding the underlying biology. Researchers hope that, over time, they will be able to predict who will benefit most based on genetics, environment and other biological factors